Thu, Dec 25, 2014, 3:26 AM EST - U.S. Markets closed for Christmas


% | $
Quotes you view appear here for quick access.

Response Genetics, Inc Message Board

  • frankfrazzano frankfrazzano Aug 26, 2013 2:03 PM Flag

    Congrats TB---great Move!

    Response Genetics acquires FDA-cleared test for solid tumors

    Response Genetics (RGDX) buys the "key assets" of Pathwork Diagnostics for $200K in cash and 500K shares of RGDX which are subject to a 10-month lock-up period.
    The deal give RGDX an "FDA-cleared, Medicare-reimbursed test for the diagnosis of metastatic, poorly differentiated and undifferentiated cancer" which had 2012 sales "in the mid seven figure range."
    The acquired test helps to determine the site of origin for tumors by comparing "the expression of 2K genes in a patient's tumor with a panel of 15 known tumor types that represent 90% of all cancers." (PR)


    Sentiment: Strong Buy

0.3677-0.0108(-2.85%)Dec 24 1:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.